Latest News

Journal Articles

Autoimmune

Could hyaluronic acid contribute to chronic white matter injury?

Can living in a sunnier climate in your youth reduce the risk of MS?

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Cerebrovascular disease

ANA 2018: key highlights and news stories

World Stroke Congress 2018: key news stories and hot topics

Could a simple test predict long-term stroke recovery?

CNS/PNS/SNS

3D printed scaffold promotes nerve cell growth for spinal cord injury

Advances in enteric neurobiology – the ‘brain’ in the gut in health and disease

SfN18: Advances in brain–computer interfaces may improve therapies and prosthetics

Cognitive/neurodegenerative disorders

Could a blood test detect Alzheimer’s before symptoms appear?

Could an experimental imaging tracer detect inflammation in neurodegenerative diseases?

Alzheimer’s disease may be prevented by experimental stroke drug

Demyelinating disease

Biomarker discovery and development in multiple sclerosis: where are we now?

US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up

Gilenya® gains EMA approval for pediatric multiple sclerosis

Development and pediatrics

US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up

Gilenya® gains EMA approval for pediatric multiple sclerosis

Artificial intelligence and home videos: a new diagnostic method for autism?

Epilepsy and seizure

Wireless ‘pacemaker for the brain’ could treat tremors and seizures in neurological diseases

Cannabidiol for epilepsy expected to be available within 6 weeks: industry news round-up

First FDA-approved cannabinoid-derived drug for seizures

Genetics

SfN18: The potential of gene therapy in neurological disorders

Treasure trove of 102 genes associated with autism identified

Monogenic neurodevelopmental disorders may not be as simple as they seem

Headache

US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up

Alzheimer’s drug development halted following toxic reaction: industry news round-up

Aimovig® receives EMA license for the prevention of migraine

Immune disorders and inflammation

Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?

FENS 2018: Immune system offers new way of treating Alzheimer’s disease

FENS 2018: Could anxiety and inflammation be treated with cannabis?

Infection

ANA 2018: key highlights and news stories

Further evidence links herpes virus to Alzheimer’s disease

Could Alzheimer’s disease be kick-started by periodontal bacteria?

Injury/trauma

‘Punch drunk syndrome’: an introduction to CTE, clinical relevance and pathology

3D printed scaffold promotes nerve cell growth for spinal cord injury

Breakthrough spinal implant helps paralyzed men walk again

Movement disorders

Wireless ‘pacemaker for the brain’ could treat tremors and seizures in neurological diseases

RESTORE-1: first patient dosed with gene therapy in Parkinson’s trial

BrainStorm scraps initial access to NurOwn® for amyotrophic lateral sclerosis

Neuro-ophthalmology

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Glaucoma research gives a glimpse of a novel neuroprotection mechanism

Management of glaucoma as a neurodegenerative disease

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

New genetic suspects identified for ALS and FTD

Novel discovery in motor neuron disease may pave the way for future treatments

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Neuropsychiatry

Mental illnesses may be treated with common somatic drugs

Warnings that stopping Gilenya® could make multiple sclerosis worse: industry news round-up

SfN18: Can animal models offer an insight into human opioid addiction, withdrawal and relapse behaviors?

Oncology/tumor

Immunotherapy may be an effective treatment for some gliomas

Sexual dimorphism in glioblastoma: an interview with Justin Lathia

Warnings that stopping Gilenya® could make multiple sclerosis worse: industry news round-up

Pain

New smartphone application could detect first signs of opioid overdose

The opioid epidemic: could a vaccine prevent addiction and overdose?

Spinal cord stimulation enables paralyzed man to walk

Sleep

SfN18: Disrupted sleep may exacerbate anxiety and brain disorders

#NCIntroduces... Sleep science

Better sleep works like a dream at reducing fear learning